Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 78
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Gynecol Oncol ; 161(1): 202-210, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33514483

RESUMEN

OBJECTIVE: To identify clinicopathological characteristics, treatment patterns, clinical outcomes and prognostic factors in patients with vulvar melanoma (VM). MATERIALS & METHODS: This retrospective multicentre cohort study included 198 women with VM treated in eight cancer centres in the Netherlands and UK between 1990 and 2017. Clinicopathological features, treatment, recurrence, and survival data were collected. Overall and recurrence-free survival was estimated with the Kaplan-Meier method. Prognostic parameters were identified with multivariable Cox regression analysis. RESULTS: The majority of patients (75.8%) had localized disease at diagnosis. VM was significantly associated with high-risk clinicopathological features, including age, tumour thickness, ulceration, positive resection margins and involved lymph nodes. Overall survival was 48% (95% CI 40-56%) and 31% (95% CI 23-39%) after 2 and 5 years respectively and did not improve in patients diagnosed after 2010 compared to patients diagnosed between 1990 and 2009. Recurrence occurred in 66.7% of patients, of which two-third was non-local. In multivariable analysis, age and tumour size were independent prognostic factors for worse survival. Prognostic factors for recurrence were tumour size and tumour type. Only the minority of patients were treated with immuno- or targeted therapy. CONCLUSION: Our results show that even clinically early-stage VM is an aggressive disease associated with poor clinical outcome due to distant metastases. Further investigation into the genomic landscape and the immune microenvironment in VM may pave the way to novel therapies to improve clinical outcomes in these aggressive tumours. Clinical trials with immunotherapy or targeted therapy in patients with high-risk, advanced or metastatic disease are highly needed.


Asunto(s)
Melanoma/mortalidad , Melanoma/terapia , Neoplasias de la Vulva/mortalidad , Neoplasias de la Vulva/terapia , Anciano , Estudios de Cohortes , Supervivencia sin Enfermedad , Femenino , Humanos , Inhibidores de Puntos de Control Inmunológico/administración & dosificación , Melanoma/patología , Persona de Mediana Edad , Terapia Molecular Dirigida , Estadificación de Neoplasias , Países Bajos/epidemiología , Pronóstico , Estudios Retrospectivos , Tasa de Supervivencia , Reino Unido/epidemiología , Neoplasias de la Vulva/patología
2.
J Low Genit Tract Dis ; 24(3): 272-276, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32205765

RESUMEN

OBJECTIVES: The aims of the study were to evaluate clinicopathologic features, management, and outcomes in vulval melanoma and to review the literature. MATERIALS AND METHODS: Data were collected retrospectively on patients with vulval melanoma from 2001 to 2017 in 5 gynecological oncology cancer centers (Bristol, Taunton, Truro, Plymouth, and Cheltenham). SPSS software was used for univariate and multivariate statistical analysis. Disease-specific median survival was calculated using Kaplan-Meier curves. RESULTS: Forty-four patients with vulval melanoma were included, with a median age of 71 years. Forty-three of 44 had wide local excision with full inguinal lymphadenectomy if abnormal lymph nodes. Seven patients had sentinel lymph nodes. However, 2 patients with negative sentinel lymph nodes had distant recurrences within 16 months.On univariate analysis, presence of ulceration (p = .012), perineural invasion (p = .03), and area of lesion (p = .016) were associated with risk of recurrence but only presence of microsatellites (p = .01) was associated with risk of death.There were 31 deaths (70%): 29 (94%) of 31 from melanoma and 28 (64%) of 44 recurrences: 17 local (10 groin, 7 vulval) and 9 distant. Overall median survival was 32.5 months (95% CI, 17.8-46.5 months) and median recurrence-free survival 12.6 months (95% CI, 7.7-17.4 months). CONCLUSIONS: This retrospective multicenter study highlights the high recurrence rate and poor prognosis of vulval melanoma. Lymph node surgery did not make any difference to recurrence-free survival or overall survival. The presence of microsatellites was associated with a statistically increased risk of death.


Asunto(s)
Melanoma/mortalidad , Melanoma/terapia , Neoplasias Cutáneas/mortalidad , Neoplasias Cutáneas/terapia , Neoplasias de la Vulva/mortalidad , Neoplasias de la Vulva/terapia , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Medición de Riesgo
3.
Can J Microbiol ; 57(3): 211-6, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21358762

RESUMEN

The activity of esterase secreted by conidia of wheat powdery mildew fungus, Blumeria graminis f. sp. tritici, was assayed using indoxyl acetate hydrolysis, which generates indigo blue crystals. Mature, ungerminated, and germinating conidia secrete esterase(s) on artificial media and on plant leaf surfaces. The activity of these esterases was inhibited by diisopropyl fluorophosphate, which is selective for serine esterases. When conidia were inoculated on wheat leaves pretreated with diisopropyl fluorophosphate, both appressorial germ tube differentiation and symptom development were significantly impaired, indicating an important role of secreted serine esterases in wheat powdery mildew disease establishment.


Asunto(s)
Ascomicetos/enzimología , Esterasas/metabolismo , Proteínas Fúngicas/metabolismo , Triticum/microbiología , Ascomicetos/efectos de los fármacos , Ascomicetos/crecimiento & desarrollo , Isoflurofato/farmacología , Enfermedades de las Plantas/microbiología , Hojas de la Planta/microbiología , Esporas Fúngicas/efectos de los fármacos , Esporas Fúngicas/enzimología , Esporas Fúngicas/crecimiento & desarrollo
4.
Mol Plant Microbe Interact ; 22(12): 1601-10, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19888825

RESUMEN

The biotrophic powdery mildew fungus Blumeria graminis releases extracellular materials to the surface of fungal infection structures that facilitate anchoring them to hydrophobic plant surfaces prior to infection; however, the chemistry of fungal adhesives and the mechanism of adhesion remain largely unclear. Expressed sequence tag analysis led to identification of a secreted lipase, Lip1, from B. graminis. Expression of LIP1 is dramatically upregulated during the early stages of fungal development. Lip1, secreted to the surface of fungal cell walls, possesses lipolytic activity against a broad range of glycerides and releases alkanes and primary fatty alcohols from the epicuticular wax of wheat leaves. Of the epicuticular wax components released by Lip1 activity, long-chain alkanes are the most efficient cues for triggering appressorium formation. Pretreatment of wheat leaves with Lip1, thereby removing leaf surface wax, severely compromises components of fungal pathogenicity, including conidial adhesion, appressorium formation, and secondary hypha growth. Our data suggest that Lip1 activity releases cues from the host surface to promote pathogen development and infection.


Asunto(s)
Ascomicetos/enzimología , Lipasa/metabolismo , Epidermis de la Planta , Ceras , Regulación Enzimológica de la Expresión Génica , Regulación Fúngica de la Expresión Génica , Lipasa/genética , Datos de Secuencia Molecular , Hojas de la Planta/microbiología , Esporas Fúngicas , Especificidad por Sustrato , Triticum/microbiología
5.
Emerg Med Australas ; 35(1): 3, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36645834
6.
Emerg Med Australas ; 35(4): 539, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37454366
7.
Emerg Med Australas ; 35(5): 717, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37717269
8.
Emerg Med Australas ; 35(6): 893, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37972219
9.
Emerg Med Australas ; 34(2): 149, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35307957
10.
Emerg Med Australas ; 34(6): 851, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36378263
11.
Emerg Med Australas ; 34(3): 309, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-35591801
12.
Emerg Med J ; 28(2): 90, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21148570
20.
Emerg Med Australas ; 33(6): 959, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34784111
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA